• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Tumor-Associated Macrophages Associate with Cerebrospinal Fluid Interleukin-10 and Survival in Primary Central Nervous System Lymphoma (PCNSL).肿瘤相关巨噬细胞与原发性中枢神经系统淋巴瘤(PCNSL)中的脑脊液白细胞介素-10及生存情况相关。
Brain Pathol. 2016 Jul;26(4):479-87. doi: 10.1111/bpa.12318. Epub 2015 Oct 12.
2
Combined tumor-associated macrophages biomarker predicting extremely poor outcome of patients with primary central nervous system lymphoma.联合肿瘤相关巨噬细胞生物标志物预测原发性中枢神经系统淋巴瘤患者的极差预后。
Hematol Oncol. 2021 Dec;39(5):625-638. doi: 10.1002/hon.2926. Epub 2021 Sep 20.
3
Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (PCNSL).脑脊液白细胞介素-10 可能是免疫功能正常的原发性中枢神经系统淋巴瘤(PCNSL)的有用生物标志物。
Neuro Oncol. 2012 Mar;14(3):368-80. doi: 10.1093/neuonc/nor203. Epub 2011 Dec 12.
4
M2 macrophage/microglial cells induce activation of Stat3 in primary central nervous system lymphoma.M2巨噬细胞/小胶质细胞可诱导原发性中枢神经系统淋巴瘤中Stat3的激活。
J Clin Exp Hematop. 2011;51(2):93-9. doi: 10.3960/jslrt.51.93.
5
Cerebrospinal Fluid IL-10 and IL-10/IL-6 as Accurate Diagnostic Biomarkers for Primary Central Nervous System Large B-cell Lymphoma.脑脊液 IL-10 和 IL-10/IL-6 作为原发性中枢神经系统大 B 细胞淋巴瘤的准确诊断生物标志物。
Sci Rep. 2016 Dec 7;6:38671. doi: 10.1038/srep38671.
6
Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study.原发性中枢神经系统淋巴瘤患者脑脊液中白细胞介素检测的临床病理分析及特异性鉴别标志物:一项回顾性研究结果。
Ann Hematol. 2023 Aug;102(8):2153-2163. doi: 10.1007/s00277-023-05301-7. Epub 2023 Jun 8.
7
Changes in cerebrospinal fluid interleukin-10 levels display better performance in predicting disease relapse than conventional magnetic resonance imaging in primary central nervous system lymphoma.脑脊液白细胞介素-10 水平的变化在预测原发性中枢神经系统淋巴瘤的疾病复发方面优于传统磁共振成像。
BMC Cancer. 2021 Feb 22;21(1):183. doi: 10.1186/s12885-020-07774-5.
8
The CSF IL-10 concentration is an effective diagnostic marker in immunocompetent primary CNS lymphoma and a potential prognostic biomarker in treatment-responsive patients.脑脊液中 IL-10 的浓度是免疫功能正常的原发性中枢神经系统淋巴瘤的有效诊断标志物,也是治疗反应患者的潜在预后生物标志物。
Eur J Cancer. 2016 Jul;61:69-76. doi: 10.1016/j.ejca.2016.03.080. Epub 2016 May 5.
9
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.MYD88 L265P 突变和脑脊液中白细胞介素-10 的检测是原发性中枢神经系统淋巴瘤患者具有高度特异性的鉴别标志物:一项前瞻性研究的结果。
Br J Haematol. 2021 May;193(3):497-505. doi: 10.1111/bjh.17357. Epub 2021 Feb 23.
10
The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.EB 病毒阳性原发性中枢神经系统淋巴瘤的血管周围微环境:程序性细胞死亡 1 和程序性细胞死亡配体 1 的作用。
Neuropathology. 2018 Apr;38(2):125-134. doi: 10.1111/neup.12435. Epub 2017 Oct 24.

引用本文的文献

1
Single-cell and spatial characterization of plasmablast-like lymphoma cells in primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤中浆母细胞样淋巴瘤细胞的单细胞和空间特征分析
Blood Neoplasia. 2024 Nov 15;2(1):100058. doi: 10.1016/j.bneo.2024.100058. eCollection 2025 Feb.
2
New hopes and challenges in targeted therapy and immunotherapy for primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤靶向治疗和免疫治疗的新希望与挑战
Front Immunol. 2025 Feb 18;16:1438001. doi: 10.3389/fimmu.2025.1438001. eCollection 2025.
3
Cerebrospinal fluid IL-6 and IL-10 as promising diagnostic and therapeutic prognostic biomarkers for secondary central nervous system lymphoma.脑脊髓液中白介素 6 和白介素 10 作为二级中枢神经系统淋巴瘤有前途的诊断和治疗预后生物标志物。
BMC Cancer. 2024 Nov 22;24(1):1443. doi: 10.1186/s12885-024-13195-5.
4
Tumor microenvironment in primary central nervous system lymphoma (PCNSL).原发性中枢神经系统淋巴瘤(PCNSL)的肿瘤微环境。
Cancer Biol Ther. 2024 Dec 31;25(1):2425131. doi: 10.1080/15384047.2024.2425131. Epub 2024 Nov 18.
5
Association of preoperative seizures with reduced expression of soluble CD163, an M2 macrophage marker, in the cerebrospinal fluid in isocitrate dehydrogenase wild-type glioblastoma.术前癫痫发作与异柠檬酸脱氢酶野生型胶质母细胞瘤脑脊液中M2巨噬细胞标志物可溶性CD163表达降低之间的关联。
J Neurooncol. 2025 Jan;171(1):95-103. doi: 10.1007/s11060-024-04837-6. Epub 2024 Oct 8.
6
Comparative analyses of immune cells and alpha-smooth muscle actin-positive cells under the immunological microenvironment between with and without dense fibrosis in primary central nervous system lymphoma.原发性中枢神经系统淋巴瘤中致密纤维化与无致密纤维化免疫微环境下免疫细胞和α-平滑肌肌动蛋白阳性细胞的比较分析。
Brain Tumor Pathol. 2024 Oct;41(3-4):97-108. doi: 10.1007/s10014-024-00488-7. Epub 2024 Aug 26.
7
The research progress on radiation resistance of cervical cancer.宫颈癌放射抗性的研究进展
Front Oncol. 2024 Apr 8;14:1380448. doi: 10.3389/fonc.2024.1380448. eCollection 2024.
8
Extranodal lymphoma: pathogenesis, diagnosis and treatment.结外淋巴瘤:发病机制、诊断与治疗
Mol Biomed. 2023 Sep 18;4(1):29. doi: 10.1186/s43556-023-00141-3.
9
Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the Tohoku Brain Tumor Study Group.东北地区和新潟地区老年原发性中枢神经系统淋巴瘤预后不良的临床病理危险因素:东北脑肿瘤研究组的一项多中心回顾性队列研究。
Brain Tumor Pathol. 2022 Jul;39(3):139-150. doi: 10.1007/s10014-022-00427-4. Epub 2022 Mar 21.
10
Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma.原发性中枢神经系统淋巴瘤免疫治疗的新进展
Cancers (Basel). 2021 Oct 10;13(20):5061. doi: 10.3390/cancers13205061.

本文引用的文献

1
Tumor associated macrophage: a review on the phenotypes, traits and functions.肿瘤相关巨噬细胞:关于其表型、特征及功能的综述
Iran J Cancer Prev. 2014 Winter;7(1):1-8.
2
Expression of tumor-associated macrophage in progression of human glioma.肿瘤相关巨噬细胞在人类胶质瘤进展中的表达
Cell Biochem Biophys. 2014 Dec;70(3):1625-31. doi: 10.1007/s12013-014-0105-3.
3
Mechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissues.驱动巨噬细胞在不同肿瘤微环境中的多样性和特化的机制以及与其他组织的平行关系。
Front Immunol. 2014 Mar 26;5:127. doi: 10.3389/fimmu.2014.00127. eCollection 2014.
4
Clinical significance of macrophage heterogeneity in human malignant tumors.人类恶性肿瘤中巨噬细胞异质性的临床意义。
Cancer Sci. 2014 Jan;105(1):1-8. doi: 10.1111/cas.12314. Epub 2013 Nov 29.
5
High-infiltration of tumor-associated macrophages predicts unfavorable clinical outcome for node-negative breast cancer.肿瘤相关巨噬细胞高浸润预测淋巴结阴性乳腺癌不良临床结局。
PLoS One. 2013 Sep 30;8(9):e76147. doi: 10.1371/journal.pone.0076147. eCollection 2013.
6
Glioma grade is associated with the accumulation and activity of cells bearing M2 monocyte markers.胶质瘤级别与具有 M2 单核细胞标志物的细胞的积累和活性有关。
Clin Cancer Res. 2013 Jul 15;19(14):3776-86. doi: 10.1158/1078-0432.CCR-12-1940. Epub 2013 Jun 5.
7
Clinical significance of CD163⁺ tumor-associated macrophages in patients with adult T-cell leukemia/lymphoma.CD163+肿瘤相关巨噬细胞在成人 T 细胞白血病/淋巴瘤患者中的临床意义。
Cancer Sci. 2013 Jul;104(7):945-51. doi: 10.1111/cas.12167. Epub 2013 May 9.
8
Tumor-associated macrophages as a prognostic parameter in multiple myeloma.肿瘤相关巨噬细胞作为多发性骨髓瘤的预后参数。
Ann Hematol. 2013 May;92(5):669-77. doi: 10.1007/s00277-012-1652-6. Epub 2013 Jan 20.
9
Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.M2 极化的巨噬细胞的表达与晚期上皮性卵巢癌的不良预后相关。
Technol Cancer Res Treat. 2013 Jun;12(3):259-67. doi: 10.7785/tcrt.2012.500312. Epub 2012 Dec 26.
10
Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer.肿瘤相关巨噬细胞:在人类肺癌中的功能、表型及与预后的关联。
Am J Transl Res. 2012;4(4):376-89. Epub 2012 Oct 10.

肿瘤相关巨噬细胞与原发性中枢神经系统淋巴瘤(PCNSL)中的脑脊液白细胞介素-10及生存情况相关。

Tumor-Associated Macrophages Associate with Cerebrospinal Fluid Interleukin-10 and Survival in Primary Central Nervous System Lymphoma (PCNSL).

作者信息

Sasayama Takashi, Tanaka Kazuhiro, Mizowaki Takashi, Nagashima Hiroaki, Nakamizo Satoshi, Tanaka Hirotomo, Nishihara Masamitsu, Mizukawa Katsu, Hirose Takanori, Itoh Tomoo, Kohmura Eiji

机构信息

Department of Neurosurgery, Kobe University Graduate School of Medicine, Kobe, Japan.

Department of Neurosurgery, Nishi-Kobe Medical Center, Kobe, Japan.

出版信息

Brain Pathol. 2016 Jul;26(4):479-87. doi: 10.1111/bpa.12318. Epub 2015 Oct 12.

DOI:10.1111/bpa.12318
PMID:26314692
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8029390/
Abstract

Increased tumor-associated macrophages (TAMs) have been reported to be associated with poor prognosis in various tumors; however, the importance of TAMs in primary central nervous system lymphoma (PCNSL) has not been clarified. In 47 patients with PCNSL who were treated with high-dose methotrexate (MTX) and radiotherapy, the relationships between the infiltration levels of TAMs and the clinicopathological parameters were analyzed. Univariate analysis of the Cox proportional hazards model using continuous scales revealed that increased CD68 positive (+) TAMs was significantly associated with inferior progression-free survival (PFS) (P = 0.04), and trends were observed for the increased CD163(+)  TAMs and having shorter PFS (P = 0.05). However, increased TAMs were not associated with overall survival. Because TAMs are known to produce various cytokines, we examined the relationships between cerebrospinal fluid (CSF) cytokines and TAMs. CSF interleukin-6 (IL-6) and soluble IL-2 receptor were not correlated with the infiltration rate of TAMs; however, CSF IL-10 level was correlated with infiltration levels of CD68 and CD163(+)  TAMs. We also confirmed the expression of IL-10 in CD68(+)  and CD163(+)  TAMs by double immunostaining analysis. Our results indicate that a high level of IL-10 in CSF may be positively associated with the infiltration level of TAMs in PCNSLs.

摘要

据报道,肿瘤相关巨噬细胞(TAM)增多与多种肿瘤的不良预后相关;然而,TAM在原发性中枢神经系统淋巴瘤(PCNSL)中的重要性尚未阐明。对47例接受大剂量甲氨蝶呤(MTX)和放疗的PCNSL患者,分析了TAM浸润水平与临床病理参数之间的关系。使用连续量表对Cox比例风险模型进行单因素分析显示,CD68阳性(+)TAM增多与无进展生存期(PFS)较差显著相关(P = 0.04),并且观察到CD163(+)TAM增多与PFS较短的趋势(P = 0.05)。然而,TAM增多与总生存期无关。由于已知TAM可产生多种细胞因子,我们研究了脑脊液(CSF)细胞因子与TAM之间的关系。CSF白细胞介素-6(IL-6)和可溶性IL-2受体与TAM的浸润率无关;然而,CSF IL-10水平与CD68和CD163(+)TAM的浸润水平相关。我们还通过双重免疫染色分析证实了IL-10在CD68(+)和CD163(+)TAM中的表达。我们的结果表明,CSF中高水平的IL-10可能与PCNSL中TAM的浸润水平呈正相关。